Weight Loss with Cystinosis in South Africa

A multi-organ lysosomal disorder where kidneys, muscles, thyroid, and swallowing all shape what weight management looks like

Cystinosis is a rare lysosomal storage disorder caused by mutations in the CTNS gene, which encodes cystinosin — the transporter that moves the amino acid cystine out of lysosomes. Without it, cystine accumulates inside lysosomes throughout the body, forming crystals that progressively damage virtually every organ system: kidneys, eyes (corneal crystals), muscles, thyroid gland, pancreas, liver, and the brain. It is the most common inherited cause of Fanconi syndrome (a defect of renal tubular reabsorption) in children.

Weight management in cystinosis is complex because the disease attacks so many of the systems that control energy balance — the kidneys that regulate fluid and electrolytes, the muscles that burn calories through movement, the thyroid gland that sets the metabolic rate, and increasingly in adults, the swallowing mechanism that determines what can be eaten at all. This article explains the multi-system picture and how to approach body weight safely alongside cysteamine therapy.

Understanding How Cystinosis Affects Weight

1. Renal Fanconi Syndrome — Massive Electrolyte and Nutrient Loss

In nephropathic cystinosis, the renal proximal tubules lose their ability to reabsorb glucose, amino acids, phosphate, bicarbonate, potassium, sodium, and carnitine. This causes:

• Hypophosphataemia — low phosphate leads to rickets/osteomalacia and growth failure
• Carnitine wasting — secondary carnitine deficiency impairs fat oxidation (similar to Primary Carnitine Deficiency)
• Amino acid loss — protein is literally excreted, making it harder to build and maintain muscle
• Massive fluid needs — polyuria (excessive urination) requires large daily fluid intake; dehydration risk is real
• Electrolyte supplementation is daily and ongoing — phosphate, potassium, bicarbonate, carnitine replacements

2. Kidney Transplantation in Many Adults

Many patients with nephropathic cystinosis undergo kidney transplantation by their teens or twenties. Transplantation does not cure the systemic cystine accumulation — cysteamine must be continued lifelong post-transplant. Post-transplant immunosuppression (tacrolimus, prednisolone) can cause weight gain, glucose intolerance, and metabolic syndrome, adding a new layer of weight management complexity.

3. Muscle Wasting (Cystinosis Myopathy)

In older patients and adults, cystine crystals accumulate in muscle fibres, causing progressive myopathy. This manifests as difficulty swallowing (dysphagia), proximal muscle weakness (difficulty rising from a chair, climbing stairs), and reduced exercise capacity. Muscle wasting reduces resting metabolic rate and makes conventional exercise progressively harder.

4. Hypothyroidism

Thyroid gland cystine accumulation causes hypothyroidism in a significant proportion of older cystinosis patients. Hypothyroidism reduces metabolic rate, promotes weight gain, causes fatigue, and worsens cold sensitivity. Thyroid function should be checked regularly and levothyroxine prescribed as needed.

5. Pancreatic Insufficiency in Adults

In some adults with cystinosis, pancreatic exocrine and endocrine function deteriorates — leading to fat malabsorption and insulin-dependent diabetes. These add further complexity to calorie absorption and blood sugar management.

Cysteamine Therapy — The Foundation of Treatment

Cysteamine (Cystagon capsules or Procysbi extended-release) is the only disease-modifying drug for cystinosis. It enters lysosomes and reacts with cystine to form a mixed disulfide that exits via a different transporter, preventing crystal accumulation. It does not reverse existing damage but dramatically slows new organ involvement when started early. It is taken every 6 hours (Cystagon) or every 12 hours (Procysbi).

Cysteamine causes nausea and gastrointestinal discomfort, especially early in therapy. Taking it with food reduces nausea but may slightly reduce absorption. Your specialist will guide optimal timing. This nausea can reduce appetite and food intake, potentially contributing to undernutrition.

Cysteamine eye drops are a separate treatment for corneal crystal dissolution and do not affect systemic cystine levels.

Weight Management Goals — Age and Stage Specific

Dietary Principles for Cystinosis

1. Protein: Sufficient but Not Excessive

Adequate protein is essential to counteract amino acid urinary losses and maintain muscle mass. Protein restriction is rarely indicated in cystinosis (unlike some other metabolic conditions) unless late-stage kidney disease makes it necessary. Target 1.2-1.5 g/kg/day of high-quality protein. However, very high protein intakes can increase the metabolic acid load, stressing a kidney already struggling with Fanconi syndrome — avoid high-protein fad diets.

2. Phosphate: Dietary Sources Are Important

Because urinary phosphate wasting is severe, dietary phosphate intake is important. Dairy, legumes, nuts, and whole grains are good sources. However, phosphate supplements are still usually required — food alone cannot compensate for renal losses.

3. Carnitine: Supplement as Prescribed

Carnitine is lost in the urine in Fanconi syndrome. Secondary carnitine deficiency impairs fat oxidation. L-carnitine supplementation (as prescribed by your physician) is important for energy metabolism and muscle function — similar to the role it plays in Primary Carnitine Deficiency.

4. Avoid Excessive Dietary Cystine?

A common question is whether reducing dietary cystine (found in high-protein foods) helps reduce cystine accumulation. The answer is no — lysosomal cystine comes from protein recycling within cells, not primarily from dietary intake. Reducing dietary cystine does not meaningfully reduce lysosomal accumulation. Cysteamine therapy, not dietary cystine restriction, is the treatment.

5. For Post-Transplant Weight Management

Post-transplant patients on immunosuppression often need to:

• Reduce refined carbohydrates and sugary foods (steroid-induced glucose intolerance)
• Monitor salt intake (tacrolimus raises blood pressure)
• Aim for a 400-500 kcal/day deficit if overweight, in coordination with the transplant dietitian
• Avoid grapefruit and grapefruit juice (interacts with tacrolimus)
• Ensure adequate calcium and vitamin D (steroids reduce bone density)

Practical South African Food Considerations

Managing Dysphagia (Swallowing Difficulty)

Cystinosis myopathy affecting the swallowing muscles is a well-recognised late complication. If you notice difficulty swallowing solid foods, choking, or food sticking in the throat, this is medically significant — not just an annoyance:

• Request a formal swallowing assessment (videofluoroscopy or fiberoptic endoscopic evaluation of swallowing — FEES) from a speech-language therapist
• A texture-modified diet (minced, moist, or pureed foods) may be recommended
• Energy-dense soft foods help maintain calorie intake when texture is restricted: soft-cooked pap, smooth peanut butter (if not on a low-fat diet), yoghurt, avocado, soft eggs
• Nutritional supplements (Ensure, Sustagen available in South Africa) can supplement intake when solid food is difficult
• In severe cases, gastrostomy tube feeding (PEG) may be considered

Exercise in Cystinosis

Exercise is important but must be adapted:

• Pre-myopathy: standard moderate-intensity exercise (walking, cycling, swimming) is safe and beneficial
• With proximal muscle weakness: physiotherapy assessment; low-resistance exercises; avoid activities with high fall risk
• Post-transplant: exercise helps counteract steroid-related weight gain and bone loss; start with 150 minutes/week moderate walking
• Resistance training (light weights, resistance bands) preserves muscle mass and metabolic rate — especially important given myopathy risk
• Always stay hydrated — polyuria means fluid loss is faster than average

Monitoring in South Africa

Cystinosis requires lifelong multi-specialist monitoring:

• Renal function and electrolytes (sodium, potassium, phosphate, bicarbonate, carnitine) — monthly to quarterly
• White cell cystine level (the gold standard for cysteamine adequacy) — every 6-12 months
• Ophthalmology: slit-lamp assessment for corneal crystals annually
• Thyroid function annually from adolescence onward
• Swallowing assessment from early adulthood or at first symptoms
• Bone densitometry every 2-3 years
• Body weight and growth percentiles in children

In South Africa, nephropathic cystinosis is managed at Red Cross War Memorial Children's Hospital (Cape Town), Charlotte Maxeke Johannesburg Academic Hospital, and Steve Biko Academic Hospital (Pretoria). Adults need transition to nephrology and internal medicine services with metabolic experience. Rare Diseases South Africa (rarediseases.org.za) provides patient support.

Key Takeaways